The Effects of Intensive Blood Pressure Lowering on Markers of Mineral Metabolism in Persons with CKD in SPRINT | Zendy

Charles Ginsberg | Zendy; Ronit Katz | Zendy; Michel B. Chonchol | Zendy; Alexander L. Bullen | Zendy; Kalani L. Raphael | Zendy; William R. Zhang | Zendy; Walter T. Ambrosius | Zendy; Jeffrey T. Bates | Zendy; Javier A. Neyra | Zendy; Anthony A. Killeen | Zendy; Henry Punzi | Zendy; Michael G. Shlipak | Zendy; Joachim H. Ix | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Effects of Intensive Blood Pressure Lowering on Markers of Mineral Metabolism in Persons with CKD in SPRINT

Author(s) -

Charles Ginsberg,

Ronit Katz,

Michel B. Chonchol,

Alexander L. Bullen,

Kalani L. Raphael,

William R. Zhang,

Walter T. Ambrosius,

Jeffrey T. Bates,

Javier A. Neyra,

Anthony A. Killeen,

Henry Punzi,

Michael G. Shlipak,

Joachim H. Ix

Publication year - 2020

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.01400220

Subject(s) - medicine , sprint , blood pressure , physiology , endocrinology , physical therapy

Serum concentrations of fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) are elevated in patients with CKD, and higher concentrations are well established as risk factors for cardiovascular disease and death ([1][1]). In the Systolic Blood Pressure Intervention Trial (SPRINT),

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research